ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/12/e049650.full |
| _version_ | 1798034155658805248 |
|---|---|
| author | Michelle Allen Kieran Mccafferty Zoe Hollowood Donna Lockhart Jamie Chorlton |
| author_facet | Michelle Allen Kieran Mccafferty Zoe Hollowood Donna Lockhart Jamie Chorlton |
| author_sort | Michelle Allen |
| collection | DOAJ |
| first_indexed | 2024-04-11T20:39:25Z |
| format | Article |
| id | doaj.art-03633a5abdc944c099d71b19cc3eda46 |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-11T20:39:25Z |
| publishDate | 2021-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-03633a5abdc944c099d71b19cc3eda462022-12-22T04:04:14ZengBMJ Publishing GroupBMJ Open2044-60552021-12-01111210.1136/bmjopen-2021-049650ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19Michelle Allen0Kieran Mccafferty1Zoe Hollowood2Donna Lockhart3Jamie Chorlton4Department of Nephrology, Barts Health NHS Trust, London, UKDepartment of Nephrology, Barts Health NHS Trust, London, UKSt George Street Capital, London, UKSt George Street Capital, London, UKSt George Street Capital, London, UKhttps://bmjopen.bmj.com/content/11/12/e049650.full |
| spellingShingle | Michelle Allen Kieran Mccafferty Zoe Hollowood Donna Lockhart Jamie Chorlton ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19 BMJ Open |
| title | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19 |
| title_full | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19 |
| title_fullStr | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19 |
| title_full_unstemmed | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19 |
| title_short | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19 |
| title_sort | arcadia study protocol a phase ii randomised double blind placebo controlled clinical trial to assess the safety and efficacy of azd1656 in patients with diabetes hospitalised with suspected or confirmed covid 19 |
| url | https://bmjopen.bmj.com/content/11/12/e049650.full |
| work_keys_str_mv | AT michelleallen arcadiastudyprotocolaphaseiirandomiseddoubleblindplacebocontrolledclinicaltrialtoassessthesafetyandefficacyofazd1656inpatientswithdiabeteshospitalisedwithsuspectedorconfirmedcovid19 AT kieranmccafferty arcadiastudyprotocolaphaseiirandomiseddoubleblindplacebocontrolledclinicaltrialtoassessthesafetyandefficacyofazd1656inpatientswithdiabeteshospitalisedwithsuspectedorconfirmedcovid19 AT zoehollowood arcadiastudyprotocolaphaseiirandomiseddoubleblindplacebocontrolledclinicaltrialtoassessthesafetyandefficacyofazd1656inpatientswithdiabeteshospitalisedwithsuspectedorconfirmedcovid19 AT donnalockhart arcadiastudyprotocolaphaseiirandomiseddoubleblindplacebocontrolledclinicaltrialtoassessthesafetyandefficacyofazd1656inpatientswithdiabeteshospitalisedwithsuspectedorconfirmedcovid19 AT jamiechorlton arcadiastudyprotocolaphaseiirandomiseddoubleblindplacebocontrolledclinicaltrialtoassessthesafetyandefficacyofazd1656inpatientswithdiabeteshospitalisedwithsuspectedorconfirmedcovid19 |